CLINICAL_TRIALS
approval
· 2019-02-04
Clinical Trial Update: Emergency/Compassionate Use - Muscular VSD Occluder
Summary
Abbott Medical Devices' Muscular VSD Occluder has been approved for marketing to treat muscular ventricular septal defects.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Abbott Medical Devices | Conditions: Muscular, Ventricular | Status: APPROVED_FOR_MARKETING